Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 215

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 215
---
 transition costs in connection with the Business Combination. APx and the Company expect to incur significant, non -recurringcosts in connection with consummating the Business Combination. Most of these costs are payable regardless of whether the Business Combination is completed. Transaction expenses as a result of the Business Combination are currently estimated at approximately $9.66 million in the aggregate, which is comprised of fees associated with legal, audit, printing and mailing of the proxy statement/prospectus, investor relations, insurance, and other operating costs related to the Business Combination. If APx does not consummate the Business Combination, it will be required to pay its own fees and expenses, and APx likely will not have sufficient cash available to pay its fees and expenses unless and until it completes a subsequent business combination transaction. If APx is unable to complete the Business Combination, the Public Shareholders may only receive their pro rata portion of the funds in the Trust Account that are available for distribution to Public Shareholders, and the Public Warrants will expire worthless. If APx does not complete the Business Combination for any number of reasons, including those beyond APx’s control, the costs incurred up to that point for the Business Combination likely would not be recoverable. Any such event will result in a loss to APx of the related costs incurred which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If APx is unable to complete the Business Combination, the Public Shareholders may only receive their pro rata portion of the funds in the Trust Account that are available for distribution to the Public Shareholders, and the Public Warrants will expire worthless. APx may not have sufficient funds to satisfy indemnification claims of the Initial Shareholders. APx has agreed to indemnify the Initial Shareholders to the fullest extent permitted by law. However, the Initial Shareholders have agreed to waive any right, title, interest or claim of any kind in or to any monies in the Trust Account and to not seek recourse against the Trust Account for any reason whatsoever. Accordingly, any indemnification provided will be able to be satisfied by APx only if (i) APx has sufficient funds outside of the Trust Account or (ii) APx consummates the Business Combination. APx’s obligation to indemnify its officers and directors may discourage shareholders from bringing a lawsuit against the Initial Shareholders for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against the Initial Shareholders, even though such